Skip to main content

Table 2 Biomarker concentrations at baseline and follow-up in serum and synovial fluid after acute knee injury

From: Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254)

 

Synovial Fluid Levels

Serum Levels

Serum vs Synovial Fluid

Biomarker

Baseline Mean ±SD

Follow Up Mean ±SD

P-value

Baseline Mean ±SD

Follow Up Mean ±SD

P-value

Mean Ratio (synovial fluid/serum levels) ± SD, P-value

Correlation (between serum and synovial fluid levels), P-value

Inflammation markers

   IL-1β (pg/ml)

1.02 ± 0.66

0.61 ± 0.22

P = 0.124

0.17 ± 0.06

0.24 ± 0.12

P = 0.102

↑4.3 ± 2.1, p < 0.0001

rs = 0.358, P = 0.123

   CRP (μg/ml)

1.67 ± 1.28

0.68 ± 0.64

P = 0.039

3.18 ± 2.93

1.78 ± 2.10

P = 0.102

↓3.5 ± 4.2, p = 0.012

r s = 0.658, P = 0.002

Proteoglycan markers

   GAG (μg/ml)

330.7 ± 203.2

170.2 ± 45.9

P = 0.008

---

---

---

---

---

   ARGS aggrecan (μg/ml)

230.7 ± 236.7

63.2 ± 54.0

P = 0.004

---

---

---

---

---

   FA846 (ng/ml)

1134.0 ± 158.1

886.5 ± 295.8

P = 0.074

31.2 ± 35.1

32.4 ± 43.8

P = 0.520

↑59.1 ± 6.3, p = 0.0001

r s = -0.179, P = 0.464

   CS846 (ng/ml)*

---

---

---

72.3 ± 139.2

58.1 ± 131.6

P = 0.413

---

---

Collagen markers

   C2C (ng/ml)

184.1 ± 37.6

208.9 ± 56.3

P = 0.301

226.5 ± 34.8

216.3 ± 49.2

P = 0.700

↓1.2 ± 0.5, p = 0.232

rs = -0.463, P = 0.046

   CTxII (μg/L)

0.59 ± 0.58

1.09 ± 0.63

P = 0.012

---

---

---

---

---

   C1,2C (μg/ml)

0.28 ± 0.10

0.37 ± 0.08

P = 0.039

0.53 ± 0.18

0.51 ± 0.19

P = 0.638

↓1.8 ± 1.2, p = 0.005

rs = 0.209, P = 0.391

   CTxI (ng/ml)

0.75 ± 0.39

1.23 ± 0.67

P = 0.004

0.52 ± 0.32

0.66 ± 0.31

P = 0.083

↑1.6 ± 0.5, p = 0.0002

rs = 0.819, P < 0.0001

   NTx (nM BCE)

15.58 ± 4.37

19.64 ± 7.78

P = 0.008

18.67 ± 6.92

21.6 ± 4.2

P = 0.054

↑1.2 ± 0.2, p = 0.012

rs = 0.828, P < 0.0001

   CPII (ng/ml)

308.1 ± 257.4

318.3 ± 185.1

P = 0.820

365.2 ± 181.5

288.2 ±106.8

P = 0.102

↑1.3 ± 0.9, p = 0.976

rs = -0.102, P = 0.679

Osteocalcin (ng/ml)

15.43 ± 4.99

17.08 ± 6.16

P = 0.301

19.91 ± 8.54

16.3 ± 5.6

P = 0.032

↑1.2 ± 0.3, p = 0.012

rs = 0.747, P = 0.0002

Post-translational markers of protein age

   β-Aspartate (μM)

0.94 ± 0.32

0.76 ± 0.37

P = 0.129

---

---

---

---

---

   D-Asx (D/D+L)

0.018 ± 0.001

0.019 ± 0.002

P = 0.423

---

---

---

---

---

   D-Serine (D/D+L)

0.002 ± 0.001

0.003 ± 0.001

P = 0.055

---

---

---

---

---

Other Biomarkers

   sCD44 (ng/ml)*

128.1 ± 49.0

105.0 ± 28.2

P = 0.250

115.9 ± 26.9

110.7 ± 39.0

P = 0.820

↑1.1 ± 0.4, p = 0.922

rs = 0.301, P = 0.226

   COMP (μg/ml)

140.9 ± 65.4

99.1 ± 32.3

P = 0.055

8.6 ± 4.1

8.0 ± 4.4

P = 0.278

↑21.2 ± 15.3, P = 0.0001

rs = -0.326, P = 0.173

   Tenascin C (ng/ml)

813.2 ± 428.6

908 ± 599

P = 0.570

---

---

---

---

---

   Lubricin (nM equ)

390.4 ± 159.6

215.9 ± 59.0

P = 0.008

---

---

---

---

---

   MMP-3 (ng/ml)

29.02 ± 20.84

30.89 ± 26.56

P = 0.910

0.05 ± 0.02

0.04 ± 0.02

P = 0.148

↑738.8 ± 602.5, P = 0.0001

rs = 0.479, P = 0.038

  1. Results represent mean ± SD data for n = 9 patients for synovial fluid values and for serum n = 11 or n = 9 for * marked biomarkers due to sample depletion. Non-parametric paired analyses by Wilcoxon Signed Rank test were performed to evaluate for significant differences between baseline and follow up time points and between serum and synovial fluid values. Non parametric Spearman Rank correlations (r s ) were performed to determine correlations between synovial fluid and serum and the ratios reported are mean ratios ± SD.